WAVE LIFE SCIENCES LTD. Increase (Decrease) in Contract with Customer, Liability
WAVE LIFE SCIENCES LTD. (WVE) reported Increase (Decrease) in Contract with Customer, Liability of -$29.63 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-07-30
- WAVE LIFE SCIENCES LTD. increase (decrease) in contract with customer, liability for the quarter ending 2026-06-30 was -$1.39M.
- WAVE LIFE SCIENCES LTD. increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was -$28.25M.
- WAVE LIFE SCIENCES LTD. increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was -$5.97M.
- WAVE LIFE SCIENCES LTD. increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was $2.39M, a 68.84% decline year-over-year.
- WAVE LIFE SCIENCES LTD. increase (decrease) in contract with customer, liability for fiscal 2025 was -$19.83M.
- WAVE LIFE SCIENCES LTD. increase (decrease) in contract with customer, liability for fiscal 2024 was -$93.59M, a 272.27% decline from fiscal 2023.
- WAVE LIFE SCIENCES LTD. increase (decrease) in contract with customer, liability for fiscal 2023 was $54.33M.
- WAVE LIFE SCIENCES LTD. increase (decrease) in contract with customer, liability for fiscal 2022 was -$3.25M.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$29.63M 10-Q · filed 2026-07-30 | -$35.60M derived: sum of 3 quarters · filed 2026-07-30 | -$33.21M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | -$28.25M 10-Q · filed 2026-04-28 | -$34.21M derived: sum of 2 quarters · filed 2026-04-28 | -$31.82M derived: sum of 3 quarters · filed 2026-04-28 | -$38.90M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | -$5.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$3.58M derived: sum of 2 quarters · filed 2026-02-26 | -$10.66M derived: sum of 3 quarters · filed 2026-07-30 | -$19.83M 10-K · filed 2026-02-26 |
| 2025-09-30 | $2.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$4.69M derived: sum of 2 quarters · filed 2026-07-30 | -$13.87M 10-Q · filed 2025-11-10 | -$96.19M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | -$7.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$16.26M 10-Q · filed 2026-07-30 | -$98.58M derived: sum of 3 quarters · filed 2026-07-30 | -$90.91M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | -$9.18M 10-Q · filed 2026-04-28 | -$91.50M derived: sum of 2 quarters · filed 2026-04-28 | -$83.82M derived: sum of 3 quarters · filed 2026-04-28 | -$90.23M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | -$82.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$74.65M derived: sum of 2 quarters · filed 2026-02-26 | -$81.05M derived: sum of 3 quarters · filed 2026-02-26 | -$93.59M 10-K · filed 2026-02-26 |
| 2024-09-30 | $7.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.27M derived: sum of 2 quarters · filed 2025-11-10 | -$11.26M 10-Q · filed 2025-11-10 | -$19.23M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$6.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | -$18.94M 10-Q · filed 2025-07-30 | -$26.91M derived: sum of 3 quarters · filed 2026-02-26 | -$68.95M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$12.54M 10-Q · filed 2025-05-08 | -$20.51M derived: sum of 2 quarters · filed 2026-02-26 | -$62.55M derived: sum of 3 quarters · filed 2026-02-26 | -$84.66M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$7.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$50.01M derived: sum of 2 quarters · filed 2026-02-26 | -$72.12M derived: sum of 3 quarters · filed 2026-02-26 | $54.33M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$42.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$64.15M derived: sum of 2 quarters · filed 2024-11-12 | $62.30M 10-Q · filed 2024-11-12 | $61.06M derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-06-30 | -$22.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $104.34M 10-Q · filed 2024-08-08 | $103.10M derived: sum of 3 quarters · filed 2025-03-04 | $102.95M derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-03-31 | $126.45M 10-Q · filed 2024-05-10 | $125.21M derived: sum of 2 quarters · filed 2025-03-04 | $125.06M derived: sum of 3 quarters · filed 2025-03-04 | $124.79M derived: sum of 4 quarters · filed 2025-03-04 |
| 2022-12-31 | -$1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | -$1.39M derived: sum of 2 quarters · filed 2025-03-04 | -$1.66M derived: sum of 3 quarters · filed 2025-03-04 | -$3.25M 10-K · filed 2025-03-04 |
| 2022-09-30 | -$151.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$422.00K derived: sum of 2 quarters · filed 2023-11-09 | -$2.01M 10-Q · filed 2023-11-09 | -$3.77M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$271.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$1.85M 10-Q · filed 2023-08-03 | -$3.62M derived: sum of 3 quarters · filed 2023-08-03 | -$17.54M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | -$1.58M 10-Q · filed 2023-05-03 | -$3.35M derived: sum of 2 quarters · filed 2023-05-03 | -$17.27M derived: sum of 3 quarters · filed 2023-05-03 | |
| 2021-12-31 | -$1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$15.69M derived: sum of 2 quarters · filed 2023-03-23 | -$18.46M 10-K · filed 2023-03-23 | |
| 2021-09-30 | -$13.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$16.70M 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | -$2.78M 10-Q · filed 2022-08-11 | |||
| 2020-12-31 | -$9.44M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | -$12.89M derived: sum of 2 quarters · filed 2022-03-03 | -$15.92M derived: sum of 3 quarters · filed 2022-03-03 | -$20.08M 10-K · filed 2022-03-03 |
| 2020-09-30 | -$3.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$6.48M derived: sum of 2 quarters · filed 2021-11-10 | -$10.64M 10-Q · filed 2021-11-10 | -$13.04M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | -$3.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$7.19M 10-Q · filed 2021-08-05 | -$9.59M derived: sum of 3 quarters · filed 2021-08-05 | -$12.52M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | -$4.16M 10-Q · filed 2021-05-13 | -$6.56M derived: sum of 2 quarters · filed 2021-05-13 | -$9.49M derived: sum of 3 quarters · filed 2021-05-13 | -$17.12M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | -$2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | -$5.33M derived: sum of 2 quarters · filed 2021-03-04 | -$12.96M derived: sum of 3 quarters · filed 2021-03-04 | -$15.98M 10-K · filed 2021-03-04 |
| 2019-09-30 | -$2.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$10.56M derived: sum of 2 quarters · filed 2020-11-09 | -$13.58M 10-Q · filed 2020-11-09 | -$17.20M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | -$7.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$10.65M 10-Q · filed 2020-08-10 | -$14.28M derived: sum of 3 quarters · filed 2020-08-10 | -$18.77M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | -$3.03M 10-Q · filed 2020-05-11 | -$6.65M derived: sum of 2 quarters · filed 2020-05-11 | -$11.14M derived: sum of 3 quarters · filed 2020-05-11 | $158.98M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | -$3.62M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$8.11M derived: sum of 2 quarters · filed 2020-03-02 | $162.01M derived: sum of 3 quarters · filed 2020-03-02 | $160.59M 10-K · filed 2020-03-02 |
| 2018-09-30 | -$4.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $165.63M derived: sum of 2 quarters · filed 2019-11-05 | $164.21M 10-Q · filed 2019-11-05 | $164.11M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $170.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $168.70M 10-Q · filed 2019-08-06 | $168.60M derived: sum of 3 quarters · filed 2020-03-02 | $167.29M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | -$1.42M 10-Q · filed 2019-05-10 | -$1.52M derived: sum of 2 quarters · filed 2020-03-02 | -$2.83M derived: sum of 3 quarters · filed 2020-03-02 | |
| 2017-12-31 | -$98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$1.41M derived: sum of 2 quarters · filed 2020-03-02 | -$2.89M 10-K · filed 2020-03-02 | |
| 2017-09-30 | -$1.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$2.79M 10-Q · filed 2018-11-09 | ||
| 2017-06-30 | -$1.48M 10-Q · filed 2018-08-09 | |||
| 2016-12-31 | $11.41M 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |